Terms: = Prostate cancer AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1 AND Treatment
12 results:
1. mkk4 Inhibitors-Recent Development Status and Therapeutic Potential.
Katzengruber L; Sander P; Laufer S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108658
[TBL] [Abstract] [Full Text] [Related]
2. Genistein treatment duration effects biomarkers of cell motility in human prostate.
Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA‑136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen‑activated protein kinase kinase 4.
Zhu Y; Shao S; Pan H; Cheng Z; Rui X
Mol Med Rep; 2018 Mar; 17(3):4803-4810. PubMed ID: 29328468
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.
Kadakia KC; Tomlins SA; Sanghvi SK; Cani AK; Omata K; Hovelson DH; Liu CJ; Cooney KA
J Hematol Oncol; 2015 Oct; 8():109. PubMed ID: 26444865
[TBL] [Abstract] [Full Text] [Related]
5. Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents.
Khamis ZI; Iczkowski KA; Sang QX
Med Res Rev; 2012 Sep; 32(5):1026-77. PubMed ID: 22886631
[TBL] [Abstract] [Full Text] [Related]
6. Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells.
Markaverich BM; Vijjeswarapu M; Shoulars K; Rodriguez M
J Steroid Biochem Mol Biol; 2010 Oct; 122(4):219-31. PubMed ID: 20558290
[TBL] [Abstract] [Full Text] [Related]
7. Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells.
Misra UK; Pizzo SV
Cancer Biol Ther; 2010 Jan; 9(2):142-52. PubMed ID: 20368692
[TBL] [Abstract] [Full Text] [Related]
8. mek4 function, genistein treatment, and invasion of human prostate cancer cells.
Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
[TBL] [Abstract] [Full Text] [Related]
9. TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate.
Royuela M; Rodríguez-Berriguete G; Fraile B; Paniagua R
Histol Histopathol; 2008 Oct; 23(10):1279-90. PubMed ID: 18712680
[TBL] [Abstract] [Full Text] [Related]
10. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
[TBL] [Abstract] [Full Text] [Related]
11. c-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells.
Antosiewicz J; Herman-Antosiewicz A; Marynowski SW; Singh SV
Cancer Res; 2006 May; 66(10):5379-86. PubMed ID: 16707465
[TBL] [Abstract] [Full Text] [Related]
12. Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.
Chen YR; Shrivastava A; Tan TH
Oncogene; 2001 Jan; 20(3):367-74. PubMed ID: 11313966
[TBL] [Abstract] [Full Text] [Related]